Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PRKCA | P17252 | 5/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4978268 | 0.94 | NAAA (0.82) | NAAASMN1; SMN2DGKAPRKCA | |
| SCHEMBL27754645 | 0.92 | NAAA (0.64) | NAAASMN1; SMN2DGKAALDH1A1PRKCA | |
| SCHEMBL28906804 | 0.92 | NAAA (0.64) | NAAASMN1; SMN2CES2CES1DGKA | |
| SCHEMBL28454438 | 0.92 | NAAA (0.86) | NAAASMN1; SMN2DGKAPRKCA | |
| SCHEMBL30915389 | 0.92 | NAAA (0.86) | NAAASMN1; SMN2DGKAPRKCA | |
| SCHEMBL16046795 | 0.92 | NAAA (0.86) | NAAASMN1; SMN2DGKAPRKCA | |
| SCHEMBL28110502 | 0.92 | NAAA (0.86) | NAAASMN1; SMN2DGKAPRKCA | |
| SCHEMBL8691439 | 0.92 | NAAA (0.79) | NAAASMN1; SMN2CES2CES1DGKA | |
| SCHEMBL4978860 | 0.92 | NAAA (0.86) | NAAASMN1; SMN2CES2CES1DGKA | |
| SCHEMBL27913647 | 0.92 | NAAA (0.86) | NAAASMN1; SMN2DGKAPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023168974-A1 | CHOLIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF AS TGR5 ALLOSTERIC AGONIST | 常州大学 | 2023-09-14 | — | — | WO | disclosed |
| US-11542397-B2 | Liquid composition, quantum dot-containing film, optical film, light-emitting display element panel, and light-emitting display device | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-01-03 | — | — | US | disclosed |
| US-20210309866-A1 | LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LIGHT-EMITTING DISPLAY ELEMENT PANEL, AND LIGHT-EMITTING DISPLAY DEVICE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-10-07 | — | — | US | disclosed |
| EP-3812805-A1 | LIQUID COMPOSITION, QUANTUM DOT-CONTAINING FILM, OPTICAL FILM, LUMINESCENT DISPLAY ELEMENT PANEL, AND LUMINESCENT DISPLAY DEVICE | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-04-28 | — | — | EP | disclosed |
| CN-112479854-A | Green process for producing cyclopropyl formic acid | 苏州扬科新材料科技有限公司 | 2021-03-12 | — | — | CN | disclosed |
| CN-112334795-A | Liquid composition, quantum dot-containing film, optical film, light-emitting display element panel, and light-emitting display device | 东京应化工业株式会社 | 2021-02-05 | — | — | CN | disclosed |
| US-5827863-A | Pyrazole derivatives as angiotensin II antagonists | J. URIACH & CIA, S.A. (ES) | 1998-10-27 | — | — | US | disclosed |